Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01788514 · ClinicalTrials.gov registry record · NA

Combining Entertainment & Influenza Education for Pediatric Patients

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT01788514: Completed NA study, sponsored by NYU Langone Health.

NCT01788514 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01788514, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

The investigators have developed an influenza-vaccination-education-study-program that will involve the use of an animated influenza vaccine-based computer program (videogame) that is designed from the investigator's own initiative. The investigators propose implementing an influenza vaccination educational program in the pediatric satellite office that serves a population that has historical low rates of influenza vaccination.

Primary Outcome

Subjects will be given a pre-intervention questionnaire to assess their basic knowledge about influenza infection. Subjects then will play a videogame, designed to be an entertainment-educational hybrid product on influenza infection and influenza vaccination subject. After the intervention, subjects will fill out a post-intervention questionnaire that will assess their knowledge about influenza infection and vaccination.

Interventions

  • OTHER Videogame

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2013-01
Est. Completion 2014-05
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT01788514 record still lists

NCT01788514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Videogame is the first listed.

NCT01788514 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01788514 about?

NCT01788514 is a clinical study titled "Combining Entertainment & Influenza Education for Pediatric Patients". The investigators have developed an influenza-vaccination-education-study-program that will involve the use of an animated influenza vaccine-based computer program (videogame) that is designed from the investigator's own initiative. The investigators propose implementing an influenza vaccination edu...

What is the current status of trial NCT01788514?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-01. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01788514?

The interventions under investigation include: Videogame (OTHER).

Who is sponsoring clinical trial NCT01788514?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01788514's enrollment target sits among peer trials

51 1279th of 2000 higher than 722 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01788514, the US trial registry maintained by the National Library of Medicine. NCT01788514 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.